Liposomal Amphotericin B, and Not Amphotericin B Deoxycholate, Improves Survival of Diabetic Mice Infected with Rhizopus oryzae

The efficacies of liposomal amphotericin B (LAmB) and amphotericin B deoxycholate (AmB) were compared in a diabetic murine model of hematogenously disseminated Rhizopus oryzae infection. At 7.5 mg/kg of body weight twice a day (b.i.d.), LAmB significantly improved overall survival compared to the ra...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Ibrahim, Ashraf S., Avanessian, Valentina, Spellberg, Brad, Edwards, John E.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC201164/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14506054/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.10.3343-3344.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!